Medtech company Catalyst OrthoSciences has received FDA 510(k) clearance for its Archer Patient-Specific Instrumentation.
The shoulder arthroplasty technology is a suite of humeral and glenoid guides that helps orthopedic surgeons improve precision, consistency and confidence, according to a Feb. 25 news release from Catalyst.
Archer PSI is indicated for anatomic and reverse shoulder procedures.
The company has launched a limited market release of Archer PSI to guide optimization before a commercial launch, the release said.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
